SOHM, Inc. (SHMN)

OTCMKTS · Delayed Price · Currency is USD
0.0009
+0.0001 (12.50%)
Apr 23, 2025, 12:41 PM EDT
-47.06%
Market Cap 1.81M
Revenue (ttm) 1.30M
Net Income (ttm) -1.13M
Shares Out 2.02B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 162,900
Average Volume 1,757,055
Open 0.0009
Previous Close 0.0009
Day's Range 0.0008 - 0.0009
52-Week Range 0.0004 - 0.0017
Beta 0.22
RSI 59.87
Earnings Date n/a

About SOHM, Inc.

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based i... [Read more]

Sector Healthcare
Founded 2005
Employees 145
Stock Exchange OTCMKTS
Ticker Symbol SHMN
Full Company Profile

Financial Performance

In 2012, SOHM, Inc.'s revenue was $1.30 million, a decrease of -3.27% compared to the previous year's $1.34 million. Losses were -$1.13 million, 106.1% more than in 2011.

Financial Statements

News

SOHM, Inc. Announces Patent Allowance/Approval in South Korea

CHINO HILLS, CA / ACCESS Newswire / April 16, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editi...

7 days ago - Accesswire

SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE

CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to announc...

13 days ago - Accesswire

SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations

CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce th...

16 days ago - Accesswire

SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology

CHINO HILLS, CA / ACCESS Newswire / March 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, has announced today Gr...

6 weeks ago - Accesswire

SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant

CHINO HILLS, CA / ACCESSWIRE / November 20, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has appoin...

5 months ago - Accesswire

SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes

For Pharmaceutical, Nutraceutical, Cosmeceutical & Strategic Partnered Products CHINO HILLS, CA / ACCESSWIRE / November 14, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology compan...

5 months ago - Accesswire

SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor

CHINO HILLS, CA / ACCESSWIRE / October 22, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has appoint...

6 months ago - Accesswire

SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space

CHINO HILLS, CA / ACCESSWIRE / October 2, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has filed ne...

7 months ago - Accesswire

SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders

CHINO HILLS, CA / ACCESSWIRE / September 25, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today that the company has recei...

7 months ago - Accesswire

SOHM, Inc., Announce Dr. Tetsuya Kawamura Ph. D. Joined as a Cell Engineer and Biochemist

CHINO HILLS, CA / ACCESSWIRE / August 2, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering nume...

9 months ago - Accesswire

SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers

CHINO HILLS, CA / ACCESSWIRE / July 30, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today the dispatch of its first initi...

9 months ago - Accesswire

SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University

CHINO HILLS, CA / ACCESSWIRE / July 25, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnologycompany that manufactures and markets generic drugs covering numero...

9 months ago - Accesswire

SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor

CHINO HILLS, CA / ACCESSWIRE / June 10, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numer...

11 months ago - Accesswire

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024

SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain SOHM, Inc. Further Advances its Work in the Field of Genome ...

1 year ago - GlobeNewsWire

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs co...

1 year ago - GlobeNewsWire

SOHM Files Provisional Patent on ABBIE's ‘Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations

CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and ...

1 year ago - GlobeNewsWire

SOHM Announces Business Outlook for 2024

CHINO HILLS, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical and cosmeceutical Company that manufactures and markets g...

1 year ago - GlobeNewsWire

SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California

CHINO HILLS, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs cov...

1 year ago - GlobeNewsWire

SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients' Brand Chewables

CHINO HILLS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs cov...

1 year ago - GlobeNewsWire

SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

CHINO HILLS, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs cov...

1 year ago - GlobeNewsWire

SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors

CHINO HILLS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs co...

1 year ago - GlobeNewsWire

SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect

CHINO HILLS, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs co...

1 year ago - GlobeNewsWire

SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor

CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs cov...

1 year ago - GlobeNewsWire

SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect

CHINO HILLS, CA / ACCESSWIRE / August 8, 2023 / SOHM, Inc. (OTC PINK:SHMN), a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numer...

1 year ago - Accesswire

SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents

CHINO HILLS, CA/ ACCESSWIRE/ / August 1, 2023 / SOHM, Inc. (OTC PINK:SHMN), a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numer...

1 year ago - Accesswire